ProCE Banner Activity

Impact of Defibrotide Initiation Timing on Survival in Adults With VOD/SOS Following HSCT: A Pooled Analysis of CUP and T-IND Cohorts

Slideset Download
Conference Coverage
Early initiation of defibrotide in adults with post-HSCT VOD/SOS improves Day +100 survival regardless of renal/pulmonary dysfunction status.

Released: December 14, 2018

Expiration: December 13, 2019

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Celgene

Dova Pharmaceuticals

Gilead Text

Incyte

Janssen Biotech Pharmacyclics Abbvie

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation

Seagen

Takeda Oncology